Showing 1401-1410 of 3494 results for "".
Is There Evidence that Topical Formulations Can Support the Microbiome?
https://practicaldermatology.com/topics/atopic-dermatitis/is-there-evidence-that-topical-formulations-can-support-the-microbiome/19826/There is a growing body of research on the importance of the microbiome as well as the potential to support a healthy microbiome through topical product selection, Dr. Friedman says.M22™ with ResurFX™ - A User's Perspective
https://practicaldermatology.com/topics/general-topics/m22-with-resurfx-a-user-s-perspective/18803/Dr. Palm shares her perspective on the M22 IPL system with non-ablative one-pass resurfacing, and why it is one of the most popular procedures in her clinic.MOC: Resistance Increases in 2015
https://practicaldermatology.com/topics/practice-management/moc-resistance-increases-in-2015/21070/Dermatologists have stepped up efforts to fight MOC requirements, and readers are weighing in.Vitiligo Uncovered: Exploring the Latest Advances in Treatment and Care
https://practicaldermatology.com/youngmd-connect/ymdc-workshops/vitiligo-uncovered-exploring-latest-advances-treatment-and-care/29519/In this on-demand webinar, Dr. Domingues and Dr. Silverberg provide a comprehensive overview of vitiligo. This session covers the various types of vitiligo, essential patient evaluation techniques, and understanding disease progression. Learn about treatment strategies from both private practice andNew Frontiers in Neurotoxins
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-frontiers-in-neurotoxins/21638/Recent innovations offer patients greater variety and potentially better outcomes.Comorbidities in Vitiligo
https://practicaldermatology.com/issues/august-2025/comorbidities-in-vitiligo/36702/Vitiligo is a chronic, acquired pigmentary disorder characterized by the progressive loss of function or destruction of melanocytes in the skin, hair follicles, and mucous membranes. In this piece, Dr. Brad Glick and colleagues explore comorbidities in vitiligo.Annual Meeting Highlights; Ortho Derm's New Cash Pay Model
https://practicaldermatology.com/videos/dermwire-tv/dermwire-tv-annual-meeting-highlights-ortho-derm-s-new-cash-pay-model/19579/The annual meeting of the American Academy of Dermatology features updates in medical, surgical, and cosmetic dermatology. Practical Dermatology Chief medical editor Dr. Neal Bhatia highlighted the breadth of coverage at the meeting. DermTube caught up with multiple presenters who shared pearls fromControversies to Take Center Stage at CSF
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/controversies-to-take-center-stage-at-csf/20340/A new venue and new speakers—and a focus on hot topics—will be part of CSF 2018.Prescribing Pitfalls, Part I: Navigate the Changing Landscape of Brand Name Drug Prescribing
https://practicaldermatology.com/topics/practice-management/prescribing-pitfalls-part-i-navigate-the-changing-landscape-of-brand-name-drug-prescribing/21440/Prescribers increasingly need to understand drug pricing, pharmacy policies, insurance coverage, and coupon offers to ensure patients get the medications they need.Drug-Induced Dermatomyositis
https://practicaldermatology.com/topics/atopic-dermatitis/drug-induced-dermatomyositis/23357/It’s common practice to screen for underlying malignancy in dermatomyositis, but it is also important to look for drug-induced disease.